PMC9510979_01
Temporal changes of creatinine kinase (CK), cardiac troponin I (cTnI) and myocardial enzyme (AST/ALT/CK-MB). Treatments performed are indicated below the graph. MMF, Mycophenolate Mofetil.
fonc-12-954468-g001.jpg
PMC9510979_01_fonc-12-954468-g001.jpg
f1
Her symptom of incontinence improved, and her CK, CK-MB, and cTnI levels were decreased by this treatment ( Figure 1 ). During the process of glucocorticoid tapering (from 80 to 40 mg/day), her myocardial enzyme and cTnI levels rose again ( Figure 1 ), and the patient developed new-onset hoarseness.